Transforming WHEN, WHERE, and HOW services are accessed and delivered in TB affected countries.

Tuberculosis (TB) is one of the world’s deadliest infectious diseases, surpassing both HIV and malaria in combined deaths, despite being a preventable, treatable and curable disease. According to the World Health Organization’s (WHO) Global Tuberculosis Report 2021, in 2020 alone, there were 1.5 million deaths from TB and nearly 10 million people falling ill with the disease.

The Stop TB Partnership shared new data in March 2021 showing that nine countries with the highest TB burdens – accounting for 60% of the global TB burden – saw drastic declines in the diagnosis and treatment of people with TB in 2020, with an average decline of 23%. Essentially, the decline in TB treatment coverage due to service disruptions caused by the COVID-19 pandemic erased 12 years of hard-fought TB programme strengthening gains in these countries.

Our mission

Our phases/goals

  • identity

    Phase/Goal 1: Identify & select

    Identify which services, across the care journey, can be more decentralized, integrated, and people-centered and select product innovations, including digital health technologies (DHTs) and/or adjacent solutions, that will facilitate this shift

  • introduce

    Phase/Goal 2: Introduce, adopt & scale-up

    Accelerate the rapid and sustainable roll-out (from pilot to routine use) of country-selected product innovations (within five (5) years with bilateral, domestic, and/or multilateral resources)

  • integrate

    Phase/Goal 3: Integrate & make interoperable

    Automatically connect and link country-selected, rolled-out product innovations into a country’s information/case-based management system